1. Algeria at a Glance
Strategic Market Position
- ✓Large domestic demand
- ✓Strong local manufacturing
- ✓Government industrial policies
- ✓Expanding healthcare investment
- ✓Long-term market capacity

Healthcare & Pharmaceutical Market Intelligence
Manufacturing • Market Scale • Healthcare Investment • Strategic Growth. Large domestic demand, government industrial policies and expanding healthcare investment.

47.4M
Population
USD 1.45B
Annual Imports
82%
Local Production
USD 4.0–4.5B
Pharma Market
≈15%
Infertility Burden
Strategic Market Position

Key Market Indicators
USD 4.0–4.5B
Market Size • 5–6% Growth
USD 250–450M
Nutraceutical Market • 6–8% Growth
USD 90–170M
Fertility & Reproductive Healthcare
USD 20M
Annual Exports

USD 1.45B Imports • USD 20M Exports

Western Algeria • 760 Infertile Couples
74%
Primary infertility
30.4%
Male factor
29.2%
Mixed factor
27%
Female factor
90%
ICSI: most frequently used ART technique
Sources: Western Algeria clinical study of 760 infertile couples • Western Algeria ART cohort of 1,930 women (2019–2020) • Tubal factors 23.4% • Ovulatory factors 22.8% • PCOS the leading identified ovulatory disorder
Key Semen Findings & Strategic Areas

Severe OAT — 18.8%

Asthenospermia — 16.0%

Moderate OAT — 15.7%

ART expansion & fertility diagnostics

Hormonal therapies

One of Africa's largest pharmaceutical markets

Strong domestic manufacturing capacity

Government-driven industrial policies

Established ART & reproductive healthcare ecosystem

Long-term opportunities for pharmaceutical partnerships